Right ColectomyRACERNCT07123051
Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery System
An observational study of Right Colectomy, run by Distalmotion SA at 6 sites in 3 countries.
Trial summary
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted right colectomy. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Right Colectomy
- What is being tested?
- right colectomy
- Type of treatment
- Medical device
- How many people
- 33 participants
- Where
- 6 sitesin 3 countries
- Study dates
- 5 Aug 2025to Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients undergoing a right colectomy for malignant or benign indication
Who may be able to join
- Aged > 18 years
- Patient agrees to perform the 30-day follow-up assessment as per standard of care
Who cannot join
- History of radiotherapy on the target surgical area
- Patients with distant metastasis
- Any planned concomitant procedures
- History of major abdominal surgery
Trial locations and contacts
6 sites in 3 countries. Contact the study team or a site near you to ask about taking part.
6 sites in 3 countries
Switzerland3 sites, 3 recruiting
- Recruiting
Spitäler FMI AG
Interlaken
Roman Inglin, MD, i.chirurgie@spitalfmi.ch
- Recruiting
SRO AG Spital Langenthal
Langenthal, 4900
Thomas Kinsbergen, MD, +41 62 916 31 31, thomas.kinsbergen@sro.ch
- Recruiting
HOCH Health Ostschweiz Kantonsspital St. Gallen
Sankt Gallen, 9007
Walter Brunner, MD, +41 (0)71 494 13 12, walter.brunner@h-och.ch
Germany2 sites, 2 recruiting
- Recruiting
Klinikum Landkreis Erding
Erding, 85435
Jörg Theisen, MD, +49 8122 59-0, joerg.theisen@klinikum-erding.de
- Recruiting
Artemed Klinikum München Süd
Munich, 81379
Thomas Mussack, MD, +49 89 72440 224, bauchzentrum-akms@artemed.de
France1 site, 1 recruiting
- Recruiting
CH Châteauroux - Le Blanc
Châteauroux, 36000
Alexis Vinet, MD, +33 2 54 29 60 07, Alexis.Vinet@ch-chateauroux.fr
About this study
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted right colectomy.
- Conditions
- Right Colectomy
- Being tested
- right colectomy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
right colectomyDevice
Robotic-assisted right colectomy with the DEXTER robotic surgery system
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary safety outcome
Occurrence of Clavien-Dindo grades III-V adverse events
Measured: up to 30 days after surgery
Primary efficacy outcome
Successful completion of the Dexter-assisted procedure, i.e. free of any device related conversion to an open or fully laparoscopic surgical approach.
Measured: Intraoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2025
- Study start5 Aug 2025
- Primary completionMar 2027 (estimated)
- Study completionMar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Right ColectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 33 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Distalmotion SA
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Confinis
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07123051
- Sponsor's protocol ID
- 2025-01
- Acronym
- RACER
- Status last verified
- Oct 2026
- First submitted
- 8 Aug 2025
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery System
- ClinicalTrials.gov ID
- NCT07123051
- Acronym / sponsor ID
- RACER / 2025-01
- Conditions
- Right Colectomy
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 33 participants (estimated)
- Lead sponsor
- Distalmotion SAIndustry (pharma, biotech, devices)
- Collaborators
- Confinis
- Study start
- 5 Aug 2025 (actual)
- Primary completion
- Mar 2027 (estimated)
- Study completion
- Mar 2027 (estimated)
- First posted
- 14 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted right colectomy.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients undergoing a right colectomy for malignant or benign indication
Key inclusion criteria (2 listed)
- Aged > 18 years
- Patient agrees to perform the 30-day follow-up assessment as per standard of care
Key exclusion criteria (4 listed)
- History of radiotherapy on the target surgical area
- Patients with distant metastasis
- Any planned concomitant procedures
- History of major abdominal surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| right colectomyRobotic-assisted right colectomy with the DEXTER robotic surgery system | Device | – |
Primary outcome
Primary safety outcome
Time frame: up to 30 days after surgery
Occurrence of Clavien-Dindo grades III-V adverse events
Primary efficacy outcome
Time frame: Intraoperative
Successful completion of the Dexter-assisted procedure, i.e. free of any device related conversion to an open or fully laparoscopic surgical approach.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
Related trials for Right Colectomy
Recruiting
Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H)
Active, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Colon Cancer, Colon Polyp
RecruitingObservational study
Mesogastrium Metastasis in Colon Cancer
Colon Cancer
Not yet recruitingObservational study
Multicenter Prospective Study Protocol for Validating Surgical Quality Standards in D3 Lymphadenectomy for Oncological Right Hemicolectomy
Colon Neoplasms, Right Colon Tumors
Not yet recruitingObservational study
Mechanical Resistance Curves of the NTLC75 Linear Stapler During Barcelona Ileotransverse Anastomosis
Right Colon Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
6 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Right Colectomy, run by Distalmotion SA at 6 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in Switzerland, Germany, France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Pascal Lehmann (+41215105890, pascal.lehmann@distalmotion.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary safety outcome (time frame: up to 30 days after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.